# Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis

> **NCT06160596** · — · RECRUITING · sponsor: **Cure 51** · enrollment: 1020 (estimated)

## Conditions studied

- Pancreas Adenocarcinoma
- Small-cell Lung Cancer
- Glioblastoma, IDH-wildtype

## Interventions

- **GENETIC:** Long term survival multimodal analysis

## Key facts

- **NCT ID:** NCT06160596
- **Lead sponsor:** Cure 51
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2025-11-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 1020 (ESTIMATED)
- **Last updated:** 2023-12-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06160596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06160596, "Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06160596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*